Nisa Investment Advisors, LLC Xeris Biopharma Holdings, Inc. Transaction History
Nisa Investment Advisors, LLC
- $24.1 Billion
- Q4 2024
A detailed history of Nisa Investment Advisors, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 719 shares of XERS stock, worth $4,278. This represents 0.0% of its overall portfolio holdings.
Number of Shares
719
Previous 719
-0.0%
Holding current value
$4,278
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
162Shares Held
61MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$61.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$47 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$19.9 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$19.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$17.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $809M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...